Efficacy of Drug-Eluting Vertebral Artery Stenting Treatment for Atherosclerotic Vertebral Arteries Stenosis

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 144 participants.

Also called NCT05644314

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 144 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05644314
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05644314. Allocation not applicable; no masking; primary purpose treatment. Start 2022-05-01 (actual); primary completion 2026-05-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy of Drug-Eluting Vertebral Artery Stenting Treatment for Atherosclerotic Vertebral Arteries Stenosis
Condition
Vertebral Artery Stenosis
Intervention (Device)
The drug-eluting stent
Lead sponsor
Nanfang Hospital, Southern Medical University (class: other)

Record details

Record id
cardio:ct-nct05644314
Content hash
3ffe044dc302176a080b8fe2dfa24c6711800542387c4b6271790c276d425cfb